SNY vs SPRY
SNY (SNY) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
SNY (SNY) common stock.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
SNY does not have a complete income-statement cache yet.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
SNY currently screens at market cap $0. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the SNY and SPRY stock pages for the full models.
Not investment advice.